nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrochlorothiazide—SLC22A6—Acetylsalicylic acid—Kawasaki disease	0.657	1	CbGbCtD
Hydrochlorothiazide—Gastric irritation—Acetylsalicylic acid—Kawasaki disease	0.0237	0.1	CcSEcCtD
Hydrochlorothiazide—Epigastric discomfort—Acetylsalicylic acid—Kawasaki disease	0.0174	0.0738	CcSEcCtD
Hydrochlorothiazide—KCNMA1—artery—Kawasaki disease	0.0166	0.157	CbGeAlD
Hydrochlorothiazide—CA9—gall bladder—Kawasaki disease	0.0158	0.149	CbGeAlD
Hydrochlorothiazide—Peptic ulcer—Acetylsalicylic acid—Kawasaki disease	0.0137	0.0581	CcSEcCtD
Hydrochlorothiazide—Heartburn—Acetylsalicylic acid—Kawasaki disease	0.0133	0.0564	CcSEcCtD
Hydrochlorothiazide—KCNMA1—gall bladder—Kawasaki disease	0.0122	0.115	CbGeAlD
Hydrochlorothiazide—Gout—Acetylsalicylic acid—Kawasaki disease	0.00983	0.0416	CcSEcCtD
Hydrochlorothiazide—Diabetes mellitus—Acetylsalicylic acid—Kawasaki disease	0.00766	0.0324	CcSEcCtD
Hydrochlorothiazide—Polyuria—Acetylsalicylic acid—Kawasaki disease	0.00758	0.0321	CcSEcCtD
Hydrochlorothiazide—Vascular purpura—Acetylsalicylic acid—Kawasaki disease	0.00745	0.0315	CcSEcCtD
Hydrochlorothiazide—Thirst—Acetylsalicylic acid—Kawasaki disease	0.007	0.0296	CcSEcCtD
Hydrochlorothiazide—Renal impairment—Acetylsalicylic acid—Kawasaki disease	0.007	0.0296	CcSEcCtD
Hydrochlorothiazide—Purpura—Acetylsalicylic acid—Kawasaki disease	0.00691	0.0292	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal haemorrhage—Acetylsalicylic acid—Kawasaki disease	0.00666	0.0282	CcSEcCtD
Hydrochlorothiazide—KCNMA1—heart—Kawasaki disease	0.00613	0.0578	CbGeAlD
Hydrochlorothiazide—Hypokalaemia—Acetylsalicylic acid—Kawasaki disease	0.00606	0.0256	CcSEcCtD
Hydrochlorothiazide—CA2—gall bladder—Kawasaki disease	0.006	0.0566	CbGeAlD
Hydrochlorothiazide—Influenza—Acetylsalicylic acid—Kawasaki disease	0.00576	0.0243	CcSEcCtD
Hydrochlorothiazide—CA4—cardiac ventricle—Kawasaki disease	0.00554	0.0522	CbGeAlD
Hydrochlorothiazide—CA4—neck—Kawasaki disease	0.0055	0.0519	CbGeAlD
Hydrochlorothiazide—CA5B—heart—Kawasaki disease	0.00527	0.0497	CbGeAlD
Hydrochlorothiazide—CA4—myocardium—Kawasaki disease	0.00521	0.0491	CbGeAlD
Hydrochlorothiazide—Sweating—Acetylsalicylic acid—Kawasaki disease	0.00492	0.0208	CcSEcCtD
Hydrochlorothiazide—CA1—heart—Kawasaki disease	0.00465	0.0439	CbGeAlD
Hydrochlorothiazide—CA2—cardiac ventricle—Kawasaki disease	0.00459	0.0433	CbGeAlD
Hydrochlorothiazide—CA2—neck—Kawasaki disease	0.00456	0.043	CbGeAlD
Hydrochlorothiazide—CA2—myocardium—Kawasaki disease	0.00432	0.0408	CbGeAlD
Hydrochlorothiazide—Tinnitus—Acetylsalicylic acid—Kawasaki disease	0.0043	0.0182	CcSEcCtD
Hydrochlorothiazide—Flushing—Acetylsalicylic acid—Kawasaki disease	0.00428	0.0181	CcSEcCtD
Hydrochlorothiazide—Anaemia—Acetylsalicylic acid—Kawasaki disease	0.00371	0.0157	CcSEcCtD
Hydrochlorothiazide—Agitation—Acetylsalicylic acid—Kawasaki disease	0.00369	0.0156	CcSEcCtD
Hydrochlorothiazide—Angioedema—Acetylsalicylic acid—Kawasaki disease	0.00366	0.0155	CcSEcCtD
Hydrochlorothiazide—CA4—heart—Kawasaki disease	0.00364	0.0343	CbGeAlD
Hydrochlorothiazide—Vertigo—Acetylsalicylic acid—Kawasaki disease	0.0036	0.0152	CcSEcCtD
Hydrochlorothiazide—Syncope—Acetylsalicylic acid—Kawasaki disease	0.0036	0.0152	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Acetylsalicylic acid—Kawasaki disease	0.00359	0.0152	CcSEcCtD
Hydrochlorothiazide—Loss of consciousness—Acetylsalicylic acid—Kawasaki disease	0.00353	0.0149	CcSEcCtD
Hydrochlorothiazide—Chest pain—Acetylsalicylic acid—Kawasaki disease	0.00341	0.0144	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Acetylsalicylic acid—Kawasaki disease	0.00341	0.0144	CcSEcCtD
Hydrochlorothiazide—Confusional state—Acetylsalicylic acid—Kawasaki disease	0.0033	0.014	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Acetylsalicylic acid—Kawasaki disease	0.00327	0.0138	CcSEcCtD
Hydrochlorothiazide—Shock—Acetylsalicylic acid—Kawasaki disease	0.00322	0.0136	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Acetylsalicylic acid—Kawasaki disease	0.00321	0.0136	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Acetylsalicylic acid—Kawasaki disease	0.00319	0.0135	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Acetylsalicylic acid—Kawasaki disease	0.00316	0.0134	CcSEcCtD
Hydrochlorothiazide—CA2—heart—Kawasaki disease	0.00302	0.0284	CbGeAlD
Hydrochlorothiazide—CA2—skin of body—Kawasaki disease	0.00295	0.0279	CbGeAlD
Hydrochlorothiazide—Dyspnoea—Acetylsalicylic acid—Kawasaki disease	0.00292	0.0123	CcSEcCtD
Hydrochlorothiazide—Somnolence—Acetylsalicylic acid—Kawasaki disease	0.00291	0.0123	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Acetylsalicylic acid—Kawasaki disease	0.00288	0.0122	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Acetylsalicylic acid—Kawasaki disease	0.0027	0.0114	CcSEcCtD
Hydrochlorothiazide—Urticaria—Acetylsalicylic acid—Kawasaki disease	0.0026	0.011	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Acetylsalicylic acid—Kawasaki disease	0.00241	0.0102	CcSEcCtD
Hydrochlorothiazide—Pruritus—Acetylsalicylic acid—Kawasaki disease	0.00232	0.0098	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Acetylsalicylic acid—Kawasaki disease	0.00224	0.00947	CcSEcCtD
Hydrochlorothiazide—Dizziness—Acetylsalicylic acid—Kawasaki disease	0.00216	0.00916	CcSEcCtD
Hydrochlorothiazide—Vomiting—Acetylsalicylic acid—Kawasaki disease	0.00208	0.0088	CcSEcCtD
Hydrochlorothiazide—Rash—Acetylsalicylic acid—Kawasaki disease	0.00206	0.00873	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Acetylsalicylic acid—Kawasaki disease	0.00206	0.00872	CcSEcCtD
Hydrochlorothiazide—Nausea—Acetylsalicylic acid—Kawasaki disease	0.00194	0.00822	CcSEcCtD
